Aneurysm Screening Necessary for Preventing Deaths
Analysis shows that the programme for screening 65-year-old men in England for aneurysms, a potentially fatal blood vessel condition could halve deaths, and prove to be extremely cost effective for the NHS.
Carried out over 10-years, the trial found there were only 155-deaths from abdominal aortic aneurysms among those screened, compared to 296-deaths among those who did not undergo the screening.
The initial findings of the English trial of 67,770-men first prompted the government to set up an aneurysm screening programme, with all eligible men in England being screened by 2013.
Currently, the programme is running in six areas of England, and programme leaders hope to roll it across the whole of UK, over the next four years.
According to the latest results, a one-off screening test done by ultrasound, is effective over a longer time-frame than previously measured. Deaths from abdominal aortic aneurysm were cut by 42% at four years, 47% at seven years, and 48% at 10-years.
As well, screening was found to become more cost effective over time at £7,600 per year of life gained after 10-years, though a second study by Danish researchers, published in the British Medical Journal questions the expense of screening, finding it too expensive to be worthwhile.
Each year, there are 6,000-deaths in England and Wales, due to a burst aortic aneurysm caused by ballooning of the artery wall.
- Login or register to post comments
Print
Email to friend
Related Articles
- Your Own Veins Less Used For Aortic Graft Less Vulnerable To Re-infection
- Mammograms Reduce Breast Cancer Death Risk
- Tests Can Identify Young Athletes At-Risk
- Cancer Society Criticised For Criticising Breast, Prostate Cancer Screening
- Bowel Screening Programme Saves Lives
- Bowel Screening Programme Saves Lives
- Screening Programme Leads To Early Detection of Bowel Cancer
- Screening Programme Leads To Early Detection of Bowel Cancer
While, many stories have been written about the many aspects of health-care reform, there are few on how the Americans have reacted and responded...
According to data from a government-sponsored study, adding a triglyceride-lowering drug to cholesterol-fighting statins i. e Tricor, Abbott...
Abbott Laboratories hopes to win the US Food and Drug Administration’s (FDA) approval to launch its new device – MitraClip that has been designed...
International trials of Novartis AG’s blood pressure pill Diovan and diabetes drug Starlix show, which they neither prevent heart attacks, strokes...
A British fertility clinic is holding a raffle this week, with first prize a human egg by way or promoting its ‘baby profiling’ service, it...
Alarmed by the unjustified use of potentially cancer-causing CT scans, the Medicare watchdog and senior radiologists have been prompted to call on...
Increasingly, knee replacements are becoming one of the most common surgeries in America, as painful arthritis wears out the original knee which...
While, the elderly with failing memories often risk getting lost even on familiar streets, a study of Alzheimer’s patients suggests the risk is...
President Barack Obama’s healthcare bill has rallied support from Support from the Catholic Health Association, a group representing Catholic...
The debate over prostate specific antigen (PSA), the most commonly used prostate cancer screening procedure continues to grow, ever since its...
Dealing another blow to parents blaming vaccines for their children’s illness, a special U. S. court ruled Friday, vaccines containing thimerosal...
The US Food and Drug Administration (FDA) said Friday, a boxed warning will be added to Plavix, an $8-billion-a-year anti-clotting drug sold by...












